Vanguard Group Inc Enveric Biosciences, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Shares
4 transactions
About Enveric Biosciences, Inc.
- Ticker ENVB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,078,270
- Market Cap $727K
- Description
- Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...